Open Access

Evaluation of the training program for p16/ Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry


Cite

Figure 1

Study flow chart with histopathology follow-up results.
Study flow chart with histopathology follow-up results.

Figure 2

Sensitivity and specificity of p16/Ki-67 dual immunocytochemical staining (DS) for detecting CIN2+ for both students and the teacher (senior cytotechnologist).S1= student 1; S2 = student 2; SC (S1) = senior cytotechnologist – slide review after S1; SC (S2) = senior cytotechnologist – slide review after S2
Sensitivity and specificity of p16/Ki-67 dual immunocytochemical staining (DS) for detecting CIN2+ for both students and the teacher (senior cytotechnologist).S1= student 1; S2 = student 2; SC (S1) = senior cytotechnologist – slide review after S1; SC (S2) = senior cytotechnologist – slide review after S2

Figure 3

Sensitivity and specificity for the results of both students and the reference according to the number of evaluated slides.S1 = student 1; S2 = student 2
Sensitivity and specificity for the results of both students and the reference according to the number of evaluated slides.S1 = student 1; S2 = student 2

Figure 4

Joinpoint regression analysis of students’ screening times.S1 = student 1; S2 = student 2
Joinpoint regression analysis of students’ screening times.S1 = student 1; S2 = student 2

Individual comparison of p16/Ki-67 agreement and performance between students, senior technologist and reference

TrainingReviewersOPAMcNemar’s test pκ (cohen) (95% CI)
S1/Reference81.4%0.0000.512 (CI: 0.329–0,696)
S2/Reference81.4%0.0060.527 (CI: 0.349–0,705)
Initial trainingSC (S1)/ Reference94.1%0.1310.859 (CI: 0.758–0.960)
(N = 118)SC (S2)/ Reference94.1%0.1310.859 (CI: 0.758–0.960)
SC (S1)/SC (S2)100.0%/1.000 (CI: /)
S1/Reference78.3%0.0000.556 (Cl: 0.472–0.641)
S2/Reference87.2%0.7750.713 (Cl: 0.638–0.788)
Addtional (N = 383)SC (S1)/Reference86.2%0.0060.700 (Cl: 0.625–0,775)
SC (S2)/Reference86.4%0.0040.707 (Cl: 0.632–0.781)
SC (S1)/SC (S2)98.7%1.0000.973 (CI: 0.949–0.996)

p16/Ki-67 study results and CIN2+ outcome for students, senior cytotechnologist and reference

ReviewerCategories of p16/Ki67 dual staining resultInitial training (N = 118)Additional training (N = 383)
p16/Ki67 dual staining result N, (%)CIN2+ outcomes N (PV, %)*p16/Ki67 dual staining result (N, %)CIN2+ outcomes N (PV, %)*
positive91 (77.1)65 (71.4)171 (44.6)65 (38.0)
S1suspicious7 (5.9)2 (28.6)7 (1.8)2 (28.6)
negative20 (16.9)2 (10.0)205 (53.5)10 (4.9)
unsatisfactory0 (0.0)0 (0.0)0 (0.0)0 (0.0)
positive92 (78.0)66 (71.7)129 (33.7)64 (49.6)
S2suspicious2 (1.7)0 (0.0)1 (0.3)1 (100.0)
negative24 (20.3)3 (12.5)253 (66.1)12 (4.7)
unsatisfactory0 (0)0 (0.0)0 (0.0)0 (0.0)
positive83 (70.3)65 (78.3)143 (37.9)65 (45.5)
suspicious2 (1.7)2 (100.0)5 (1.3)0 (0.0)
SC (S1)negative32 (27.1)2 (6.3)235 (61.4)12 (5.1)
unsatisfactory1 (0.8)0 (0.0)0 (0.0)0 (0.0)
positive83 (70.3)65 (78.3)145 (37.9)64 (44.1)
suspicious2 (1.7)2 (100.0)4 (1.0)0 (0.0)
SC (S2)negative32 (27.1)2 (6.3)234 (61.1)13 (5.6)
unsatisfactory1 (0.8)0 (0.0)0 (0.0)0 (0.0)
positive78 (66.1)64 (82.1)114 (29.8)64 (56.1)
Referencesuspicious2 (1.7)0 (0)13 (3.4)3 (23.1)
negative38 (32.2)5 (13.2)255 (66.6)10 (3.9)
unsatisfactory0 (0.0)0 (0.0)1 (0.3)0 (0.0)
eISSN:
1581-3207
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology